1. Home
  2. ARQQ vs CERS Comparison

ARQQ vs CERS Comparison

Compare ARQQ & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$14.51

Market Cap

250.9M

Sector

Technology

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$1.98

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
CERS
Founded
2017
1991
Country
United Kingdom
United States
Employees
91
N/A
Industry
Computer Software: Prepackaged Software
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ARQQ
CERS
Price
$14.51
$1.98
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
344.4K
1.0M
Earning Date
05-21-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
$381.13
$19.95
Revenue Next Year
$212.00
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$11.52
$1.15
52 Week High
$62.00
$2.96

Technical Indicators

Market Signals
Indicator
ARQQ
CERS
Relative Strength Index (RSI) 49.76 52.85
Support Level $11.72 $1.93
Resistance Level $17.75 $2.15
Average True Range (ATR) 1.20 0.10
MACD 0.16 0.01
Stochastic Oscillator 45.72 47.54

Price Performance

Historical Comparison
ARQQ
CERS

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: